10x Genomics: Q3 Earnings Snapshot

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Tuesday reported a loss of $35.8 million in its third quarter.

On a per-share basis, the Pleasanton, California-based company said it had a loss of 30 cents.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.

The life science technology company posted revenue of $151.7 million in the period.

10x Genomics expects full-year revenue in the range of $595 million to $605 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up